---
figid: PMC4335176__fnbeh-09-00025-g0002
figlink: /pmc/articles/PMC4335176/figure/F2/
number: Figure 2
caption: Schematic illustration of pathways leading to stimulation of extracellular-regulated
  kinase (ERK) and AKT phosphorylation by fluoxetine in astrocytes. Fluoxetine binds
  to 5-HT2B receptors. The activation of the receptors induces protein kinase C (PKC)
  activity and increase of intracellular Ca2+ concentration ([Ca2+]i) by Ca2+ release
  from intracellular stores. The latter activates Zn-dependent metalloproteinases
  (MMPs) and leads to shedding of growth factor(s). The released epidermal growth
  factor receptor (EGFR) ligand stimulates phosphorylation of the EGFR. The downstream
  target of EGFR, ERK (shown in blue) is phosphorylated via the Ras/Raf/MEK pathway,
  and AKT is phosphorylated via PI3K pathway. PIK3 is also known to catalyze the formation
  of PIP3 from PIP2. During fluoxetine administration, phosphorylation of ERK and
  AKT was prevented after siRNA administration against the 5-HT2B receptor or after
  administration of inhibitors (shown in yellow) of this receptor (SB204741), of PKC
  (GF 109293X), of intracellular Ca2+ homeostasis (BAPTA/AM, an intracellular Ca2+
  chelator), of Zn-dependent MMPs (GM6001), of the receptor-tyrosine kinase of the
  EGFR (AG1478), of ERK phosphorylation (U0126, a mitogen-activated kinase (MEK) inhibitor)
  or of the AKT pathway (LY294002, a PI3K inhibitor). This inhibition is an indication
  of participation of all the inhibited factors in the normal signaling pathway. (Hertz
  et al., ).
pmcid: PMC4335176
papertitle: 'Chronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple
  gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential
  paradigm shift.'
reftext: Leif Hertz, et al. Front Behav Neurosci. 2015;9:25.
pmc_ranked_result_index: '118149'
pathway_score: 0.9544863
filename: fnbeh-09-00025-g0002.jpg
figtitle: Pathways leading to stimulation of extracellular-regulated kinase (ERK)
  and AKT phosphorylation by fluoxetine in astrocytes
year: '2015'
organisms: Homo sapiens
ndex: 0fecc511-deea-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4335176__fnbeh-09-00025-g0002.html
  '@type': Dataset
  description: Schematic illustration of pathways leading to stimulation of extracellular-regulated
    kinase (ERK) and AKT phosphorylation by fluoxetine in astrocytes. Fluoxetine binds
    to 5-HT2B receptors. The activation of the receptors induces protein kinase C
    (PKC) activity and increase of intracellular Ca2+ concentration ([Ca2+]i) by Ca2+
    release from intracellular stores. The latter activates Zn-dependent metalloproteinases
    (MMPs) and leads to shedding of growth factor(s). The released epidermal growth
    factor receptor (EGFR) ligand stimulates phosphorylation of the EGFR. The downstream
    target of EGFR, ERK (shown in blue) is phosphorylated via the Ras/Raf/MEK pathway,
    and AKT is phosphorylated via PI3K pathway. PIK3 is also known to catalyze the
    formation of PIP3 from PIP2. During fluoxetine administration, phosphorylation
    of ERK and AKT was prevented after siRNA administration against the 5-HT2B receptor
    or after administration of inhibitors (shown in yellow) of this receptor (SB204741),
    of PKC (GF 109293X), of intracellular Ca2+ homeostasis (BAPTA/AM, an intracellular
    Ca2+ chelator), of Zn-dependent MMPs (GM6001), of the receptor-tyrosine kinase
    of the EGFR (AG1478), of ERK phosphorylation (U0126, a mitogen-activated kinase
    (MEK) inhibitor) or of the AKT pathway (LY294002, a PI3K inhibitor). This inhibition
    is an indication of participation of all the inhibited factors in the normal signaling
    pathway. (Hertz et al., ).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K1
  - BRAF
  - RAF1
  - AKT3
  - MAP2K2
  - MMP16
  - ARAF
  - MAPK3
  - PRKCZ
  - PRKCA
  - EGF
  - PRKCE
  - PRKCG
  - MMP15
  - PRKCD
  - MMP27
  - MMP1
  - AKT2
  - NRAS
  - HRAS
  - KRAS
  - MAPK1
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - PRKD3
  - MMP19
  - PRKCI
  - AKT1
  - MMP21
  - MMP2
  - MMP3
  - EGFR
  - MMP8
  - MMP13
  - PRKCH
  - PRKCB
  - MMP24
  - MMP25
  - MMP28
  - MMP17
  - MMP7
  - PRKCQ
  - MMP23B
  - MMP20
  - MMP14
  - BAPTA
  - LY294002
  - SB204741
  - U0126
  - Fluoxetine
  - 5-HT
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP16
  entrez: '4325'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: НВ-EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP15
  entrez: '4324'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP27
  entrez: '64066'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP1
  entrez: '4312'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP10
  entrez: '4319'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP11
  entrez: '4320'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP12
  entrez: '4321'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP19
  entrez: '4327'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP21
  entrez: '118856'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP3
  entrez: '4314'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP8
  entrez: '4317'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP13
  entrez: '4322'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP24
  entrez: '10893'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP25
  entrez: '64386'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP28
  entrez: '79148'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP17
  entrez: '4326'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP7
  entrez: '4316'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP23B
  entrez: '8510'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP20
  entrez: '9313'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP14
  entrez: '4323'
chemicals:
- word: BAPTA
  source: MESH
  identifier: C025603
- word: LY294002
  source: MESH
  identifier: C085911
- word: SB204741
  source: MESH
  identifier: C092756
- word: U0126
  source: MESH
  identifier: C113580
- word: Fluoxetine
  source: MESH
  identifier: D005473
- word: 5-HT
  source: MESH
  identifier: D012701
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
